Study results leave search for new diabetes and heart disease treatments unresolved
Monday, March 15, 2010 - 09:51
in Health & Medicine
Treatment with the anti-hypertensive drug valsartan (Diovan) led to a modest reduction in the development of type 2 diabetes but did not significantly reduce cardiovascular events in patients with impaired glucose tolerance, according to researchers at Duke University Medical Center and the University of Oxford. They jointly reported results at the American College of Cardiology meeting today from the world's first study designed to find ways to control the progression to diabetes and cardiovascular disease in people at risk.
Read the whole article on Physorg
More from Physorg
Related
- Study results leave search for new diabetes and heart disease treatments unresolvedMon, 15 Mar 2010, 10:58:11 EDT
- ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetesSun, 14 Mar 2010, 9:37:52 EDT
- 'Pre-diabetics' face heightened risk of heart diseaseTue, 3 Mar 2009, 17:36:18 EST
- Early signs of heart disease in preadolescent children with type 1 diabetesMon, 14 Feb 2011, 16:03:20 EST
- Diabetic kidney disease on the rise in America, despite improved diabetes careTue, 21 Jun 2011, 22:34:42 EDT